Literature DB >> 6231972

The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain.

F Moroni, G Lombardi, V Carlà, G Moneti.   

Abstract

The presence of quinolinic acid (2,3-pyridinedicarboxylic acid, QA) in the rat brain has been demonstrated using a mass-spectrometric method. Distribution studies indicate that this molecule is more concentrated in the cortex (2.1 nmol/g wet weight) than in other brain areas. Tryptophan, a possible QA precursor, administered in large doses, increases the cortical content of QA. The contrary occurs when rats are pretreated with p-chlorophenylalanine, a drug capable of decreasing brain tryptophan concentration. The neurotoxin 5,7-dihydroxytryptamine is inactive. Our findings support the idea that QA merits special attention as a potential transmitter and as an endogenous excitotoxin in brain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231972     DOI: 10.1016/0006-8993(84)90984-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Agonists, antagonists and modulators of excitatory amino acid receptors in the guinea-pig myenteric plexus.

Authors:  S Luzzi; L Zilletti; S Franchi-Micheli; A M Gori; F Moroni
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

2.  Increase of adenine nucleotide hydrolysis in rat hippocampal slices after seizures induced by quinolinic acid.

Authors:  Rafael Nicolaidis; Alessandra Nejar Bruno; João José Freitas Sarkis; Diogo Onofre Souza
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

3.  Quinolinic acid phosphoribosyltransferase: preferential glial localization in the rat brain visualized by immunocytochemistry.

Authors:  C Köhler; E Okuno; P R Flood; R Schwarcz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Excitotoxicity of quinolinic acid: modulation by endogenous antagonists.

Authors:  K H Jhamandas; R J Boegman; R J Beninger; A F Miranda; K A Lipic
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

5.  Synaptosomal tryptophan uptake and efflux following lesion of central 5-hydroxytryptaminergic neurones.

Authors:  L S Wilkinson; K J Collard
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

6.  A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N-methyl-D-aspartate or quisqualate, and the effects on toxicity of 2-amino-5-phosphonovaleric acid and kynurenic acid in the rat.

Authors:  P Winn; T W Stone; M Latimer; M H Hastings; A J Clark
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

7.  NMDA receptor heterogeneity in mammalian tissues: focus on two agonists, (2S,3R,4S) cyclopropylglutamate and the sulfate ester of 4-hydroxy-(S)-pipecolic acid.

Authors:  F Moroni; A Galli; G Mannaioni; V Carla; A Cozzi; F Mori; M Marinozzi; R Pellicciari
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

8.  The disposition of intravenous L-tryptophan in healthy subjects and in patients with liver disease.

Authors:  M Rössle; R Herz; K D Mullen; D B Jones
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

9.  Transport of quinolinic acid into rabbit and rat brain.

Authors:  T M Kitt; R Spector
Journal:  Neurochem Res       Date:  1987-07       Impact factor: 3.996

Review 10.  Quinolinic acid: an endogenous neurotoxin with multiple targets.

Authors:  Rafael Lugo-Huitrón; Perla Ugalde Muñiz; Benjamin Pineda; José Pedraza-Chaverrí; Camilo Ríos; Verónica Pérez-de la Cruz
Journal:  Oxid Med Cell Longev       Date:  2013-09-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.